company background image
AFP logo

AFT Pharmaceuticals ASX:AFP Stock Report

Last Price

AU$2.60

Market Cap

AU$261.4m

7D

0.6%

1Y

-22.6%

Updated

31 Jan, 2025

Data

Company Financials +

AFT Pharmaceuticals Limited

ASX:AFP Stock Report

Market Cap: AU$261.4m

AFP Stock Overview

Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. More details

AFP fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 77.5% below our estimate of its fair value

Earnings are forecast to grow 23.68% per year

Earnings have grown 9.7% per year over the past 5 years

Risk Analysis

AFP passed our risk checks.

My Notes

Capture your thoughts, links and company narrative

AFT Pharmaceuticals Limited Competitors

Vita Life Sciences

ASX:VLS

AU$101.5m

Vitura Health

ASX:VIT

AU$44.2m

ECS Botanics Holdings

ASX:ECS

AU$19.3m

Neuren Pharmaceuticals

ASX:NEU

AU$1.8b

Price History & Performance

Summary of share price highs, lows and changes for AFT Pharmaceuticals
Historical stock prices
Current Share PriceNZ$2.60
52 Week HighNZ$3.51
52 Week LowNZ$2.15
Beta0.36
1 Month Change1.96%
3 Month Change-6.81%
1 Year Change-22.62%
3 Year Change-33.67%
5 Year Change-16.13%
Change since IPO-11.86%

Recent News & Updates

Recent updates

Shareholder Returns

AFPAU PharmaceuticalsAU Market
7D0.6%-2.8%1.3%
1Y-22.6%-5.5%10.3%

Return vs Industry: AFP underperformed the Australian Pharmaceuticals industry which returned -5.5% over the past year.

Return vs Market: AFP underperformed the Australian Market which returned 10.3% over the past year.

Price Volatility

Is AFP's price volatile compared to industry and market?
AFP volatility
AFP Average Weekly Movement9.3%
Pharmaceuticals Industry Average Movement9.6%
Market Average Movement7.9%
10% most volatile stocks in AU Market16.4%
10% least volatile stocks in AU Market2.9%

Stable Share Price: AFP has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: AFP's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997110Hartley Atkinsonwww.aftpharm.com

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, gastrointestinal, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, vitamins, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

AFT Pharmaceuticals Limited Fundamentals Summary

How do AFT Pharmaceuticals's earnings and revenue compare to its market cap?
AFP fundamental statistics
Market capAU$261.43m
Earnings (TTM)AU$10.52m
Revenue (TTM)AU$179.96m

25.5x

P/E Ratio

1.5x

P/S Ratio

Is AFP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AFP income statement (TTM)
RevenueNZ$198.51m
Cost of RevenueNZ$109.98m
Gross ProfitNZ$88.54m
Other ExpensesNZ$76.93m
EarningsNZ$11.61m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.11
Gross Margin44.60%
Net Profit Margin5.85%
Debt/Equity Ratio36.0%

How did AFP perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

16%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 09:47
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AFT Pharmaceuticals Limited is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterBell Potter
Jack CrowleyCredit Suisse
Soo RomanoffEdison Investment Research